Micrus Endovascular to get technology rights from ReVasc
Micrus Endovascular (implants and devices for cerebral vascular conditions) has signed a letter of intent to acquire rights to an ischemic stroke treatment technology from ReVasc.
- Medical Devices
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com